Cláudia Mendes Pinto
Hogan Lovells International LLPThe life sciences practice at Hogan Lovells International LLP has expertise spanning pharmaceuticals, medical devices, and healthcare regulatory issues, advising leading pharmaceutical clients on contentious and non-contentious matters. Fabien Roy acts as head of the practice, with particular knowledge of pharma, medical devices, and in vitro diagnostic devices. Cláudia Mendes Pinto is key to the team, frequently working on EU and global projects, focusing on advanced therapy medicinal products. Helene Boland is also noted.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- Adverum Biotechnologies
- Balt USA, LLC
- Celgene Corporation
- Dexcom, Inc.
- Establishment Labs
- Synapse Biomedical, Inc.
Work highlights
- Advising Adverum, a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, on setting up a GDPR-compliant framework for their upcoming clinical trials in the EU and UK and on future clinical activities in the EU/UK.
- Advising Celgene on an ongoing basis with supply chain, manufacturing, and clinical trials regulatory aspects throughout Europe.
- Advising clients on the transition of their devices from the Medical Devices Directive to the Medical Devices Regulation.
Lawyers
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.
Practice head
The lawyer(s) leading their teams.
Fabien Roy